Duration of Treatment with Ceftazidime and Aztreonam for Bacterial Infections

General Guidelines

For most bacterial infections, treatment with ceftazidime and aztreonam should be administered for 7-14 days, with treatment continued for at least 48 hours after the patient becomes asymptomatic or evidence of bacterial eradication has been obtained, as recommended by the Infectious Diseases Society of America 1
For mild to moderate infections, a 5-7 day course is generally safe and effective when patients achieve clinical stability, according to the American College of Clinical Pharmacy 1
For severe or life-threatening infections, a minimum of 7-14 days of therapy is recommended, as suggested by the Society of Critical Care Medicine 1
Immunocompromised status may necessitate longer treatment courses, as stated by the Infectious Diseases Society of America 1
Clinical improvement should be evident within 48-72 hours of initiating appropriate therapy, as recommended by the American College of Emergency Physicians 1
Premature discontinuation of therapy before clinical stability is achieved should be avoided, as warned by the American College of Clinical Pharmacy 1

For metallo-β-lactamase-producing CRE infections, ceftazidime-avibactam combined with aztreonam is recommended as the preferred treatment option, as suggested by the European Society of Clinical Microbiology and Infectious Diseases 2, 3, 4
This combination has shown significantly lower 30-day mortality and lower clinical failure rates compared to other antimicrobial therapies, as reported by the Infectious Diseases Society of America 3, 4
Prolonged infusion (3 hours) of ceftazidime-avibactam has been associated with improved 30-day survival, as found by the Society of Critical Care Medicine 3, 5